These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 30200625

  • 1. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R, Hou Z, Li JT, Yu HN, Mou YH, Guo C.
    Molecules; 2018 Sep 06; 23(9):. PubMed ID: 30200625
    [Abstract] [Full Text] [Related]

  • 2. Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors.
    Abdelaal HI, Mohamed AR, Abo-Ashour MF, Giovannuzzi S, Fahim SH, Abdel-Aziz HA, Supuran CT, Abou-Seri SM.
    Bioorg Chem; 2024 Nov 06; 152():107759. PubMed ID: 39213797
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
    Hao S, Cheng X, Wang X, An R, Xu H, Guo M, Li C, Wang Y, Hou Z, Guo C.
    Bioorg Chem; 2020 Nov 06; 104():104237. PubMed ID: 32911194
    [Abstract] [Full Text] [Related]

  • 4. Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Bonardi A, Falsini M, Catarzi D, Varano F, Di Cesare Mannelli L, Tenci B, Ghelardini C, Angeli A, Supuran CT, Colotta V.
    Eur J Med Chem; 2018 Feb 25; 146():47-59. PubMed ID: 29407972
    [Abstract] [Full Text] [Related]

  • 5. Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles.
    Hefny SM, El-Moselhy TF, El-Din N, Giovannuzzi S, Bin Traiki T, Vaali-Mohammed MA, El-Dessouki AM, Yamaguchi K, Sugiura M, Shaldam MA, Supuran CT, Abdulla MH, Eldehna WM, Tawfik HO.
    J Med Chem; 2024 May 09; 67(9):7406-7430. PubMed ID: 38642371
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG, Harej A, Sedić M, Pavelić SK, Stepanić V, Drenjančević D, Talapko J, Raić-Malić S.
    Eur J Med Chem; 2016 Nov 29; 124():794-808. PubMed ID: 27639370
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
    Ansari MF, Idrees D, Hassan MI, Ahmad K, Avecilla F, Azam A.
    Eur J Med Chem; 2018 Jan 20; 144():544-556. PubMed ID: 29289880
    [Abstract] [Full Text] [Related]

  • 8. 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases.
    Fuentes-Aguilar A, Merino-Montiel P, Montiel-Smith S, Meza-Reyes S, Vega-Báez JL, Puerta A, Fernandes MX, Padrón JM, Petreni A, Nocentini A, Supuran CT, López Ó, Fernández-Bolaños JG.
    J Enzyme Inhib Med Chem; 2022 Dec 20; 37(1):168-177. PubMed ID: 34894971
    [Abstract] [Full Text] [Related]

  • 9. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S, Winum JY, Supuran CT.
    J Med Chem; 2011 Dec 22; 54(24):8271-7. PubMed ID: 22077347
    [Abstract] [Full Text] [Related]

  • 10. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
    Stanica L, Gheorghiu M, Stan M, Polonschii C, David S, Bratu D, Dinischiotu A, Supuran CT, Gheorghiu E.
    J Enzyme Inhib Med Chem; 2017 Dec 22; 32(1):1079-1090. PubMed ID: 28783982
    [Abstract] [Full Text] [Related]

  • 11. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS, Allam HA, Mahmoud WR, Bonardi A, Nocentini A, Gratteri P, Ibrahim ES, Abdel-Aziz HA, Supuran CT.
    Eur J Med Chem; 2018 May 25; 152():1-9. PubMed ID: 29684705
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
    Lv N, Sun M, Liu C, Li J.
    Bioorg Med Chem Lett; 2017 Oct 01; 27(19):4578-4581. PubMed ID: 28888820
    [Abstract] [Full Text] [Related]

  • 13. Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Wang ZC, Qin YJ, Wang PF, Yang YA, Wen Q, Zhang X, Qiu HY, Duan YT, Wang YT, Sang YL, Zhu HL.
    Eur J Med Chem; 2013 Aug 01; 66():1-11. PubMed ID: 23777898
    [Abstract] [Full Text] [Related]

  • 14. Novel 3-substituted coumarins inspire a custom pharmacology prediction pipeline: an anticancer discovery adventure.
    Matar IK, Muhammad ZA, Gomha SM, Al-Hussain SA, Al-Ali M, Zaki ME, El-Khouly AS.
    Future Med Chem; 2024 Aug 01; 16(17):1761-1776. PubMed ID: 39230519
    [Abstract] [Full Text] [Related]

  • 15. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B, Sławiński J, Szafrański K, Angeli A, Supuran CT, Kawiak A, Wieczór M, Zielińska J, Bączek T, Bartoszewska S.
    Eur J Med Chem; 2018 Jan 01; 143():1931-1941. PubMed ID: 29146134
    [Abstract] [Full Text] [Related]

  • 16. Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX.
    Sharma A, Tiwari M, Supuran CT.
    J Enzyme Inhib Med Chem; 2014 Apr 01; 29(2):292-6. PubMed ID: 23488741
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
    Menteşe E, Güner A, Polatlı E, Emirik M, Bektaş H, Kahveci B.
    Arch Pharm (Weinheim); 2021 Mar 01; 354(3):e2000284. PubMed ID: 33146895
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
    Yu H, Hou Z, Tian Y, Mou Y, Guo C.
    Eur J Med Chem; 2018 May 10; 151():434-449. PubMed ID: 29649740
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents.
    Peerzada MN, Khan P, Ahmad K, Hassan MI, Azam A.
    Eur J Med Chem; 2018 Jul 15; 155():13-23. PubMed ID: 29852328
    [Abstract] [Full Text] [Related]

  • 20. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
    Wu XQ, Huang C, Jia YM, Song BA, Li J, Liu XH.
    Eur J Med Chem; 2014 Mar 03; 74():717-25. PubMed ID: 24119869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.